171 related articles for article (PubMed ID: 27491634)
1. Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Schmitt F; Donnelly K; Muenzner JK; Rehm T; Novohradsky V; Brabec V; Kasparkova J; Albrecht M; Schobert R; Mueller T
J Inorg Biochem; 2016 Oct; 163():221-228. PubMed ID: 27491634
[TBL] [Abstract][Full Text] [Related]
2. Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Muenzner JK; Biersack B; Kalie H; Andronache IC; Kaps L; Schuppan D; Sasse F; Schobert R
ChemMedChem; 2014 Jun; 9(6):1195-204. PubMed ID: 24648184
[TBL] [Abstract][Full Text] [Related]
3. Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities.
Kaps L; Biersack B; Müller-Bunz H; Mahal K; Münzner J; Tacke M; Mueller T; Schobert R
J Inorg Biochem; 2012 Jan; 106(1):52-8. PubMed ID: 22112840
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
5. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of ferrocenyl-ethynyl phosphine metal complexes of gold and platinum.
Fourie E; Erasmus E; Swarts JC; Jakob A; Lang H; Joone GK; VAN Rensburg CE
Anticancer Res; 2011 Mar; 31(3):825-9. PubMed ID: 21498702
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
11. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
[TBL] [Abstract][Full Text] [Related]
12. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
13. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
[TBL] [Abstract][Full Text] [Related]
14. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes.
Ray S; Mohan R; Singh JK; Samantaray MK; Shaikh MM; Panda D; Ghosh P
J Am Chem Soc; 2007 Dec; 129(48):15042-53. PubMed ID: 17988129
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.
Utku S; Ozçelik AB; Gümüş F; Yılmaz S; Arsoy T; Açık L; Celebi Keskin A
J Pharm Pharmacol; 2014 Nov; 66(11):1593-605. PubMed ID: 25109360
[TBL] [Abstract][Full Text] [Related]
16. Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels.
Mahal K; Resch M; Ficner R; Schobert R; Biersack B; Mueller T
ChemMedChem; 2014 Apr; 9(4):847-54. PubMed ID: 24678059
[TBL] [Abstract][Full Text] [Related]
17. Biological evaluation of 4,5-diarylimidazoles with hydroxamic acid appendages as novel dual mode anticancer agents.
Mahal K; Schruefer S; Steinemann G; Rausch F; Schobert R; Biersack B; Höpfner M
Cancer Chemother Pharmacol; 2015 Apr; 75(4):691-700. PubMed ID: 25618416
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.
Novohradsky V; Liu Z; Vojtiskova M; Sadler PJ; Brabec V; Kasparkova J
Metallomics; 2014 Mar; 6(3):682-90. PubMed ID: 24448555
[TBL] [Abstract][Full Text] [Related]
20. Hetero-multinuclear ruthenium(III)/platinum(II) complexes that potentially exhibit both antimetastatic and antineoplastic properties.
Anderson CM; Taylor IR; Tibbetts MF; Philpott J; Hu Y; Tanski JM
Inorg Chem; 2012 Dec; 51(23):12917-24. PubMed ID: 23150984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]